Atlas Trials

Assessment of the Biodistribution and Safety of 123-I MZINT in Healthy Subjects and Parkinson Disease Patients

Clinical trial NCT00427674 · TERMINATED

Trial details

NCT number
NCT00427674
Sponsor
Institute for Neurodegenerative Disorders
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Parkinson Disease
Start date
2007-01-01
Primary completion
2009-08-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.